Yuko Suenaga1, Kazuhiro Kitajima2, Tomonori Kanda3, Naoki Otsuki4, Ken-Ichi Nibu4, Ryohei Sasaki5, Tomoo Itoh6, Kazuro Sugimura1. 1. Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. 2. Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. kitajima@med.kobe-u.ac.jp. 3. Department of Radiology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. 4. Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. 5. Department of Radiology, Division of Radiation Oncology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. 6. Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Abstract
PURPOSE: Our aim was to investigate the diagnostic accuracy of fluorine-18-labeled fluorodeoxyglucose positron emission tomography computed tomography (FDG-PET/CT) relative to CT for detecting neck lymph node metastases in patients with squamous cell carcinoma (SCC) of the hypopharynx, oropharynx, and larynx. METHODS: Thirty-four patients with SCC of the hypopharynx (n = 20), oropharynx (n = 5), and larynx (n = 9) who underwent neck dissection (29 bilateral, 5 unilateral; a total of 355 nodal levels) were assessed. Two observers determined the long-axis diameter and maximum standardized uptake value (SUVmax) of all visible neck nodes. Results of FDG-PET/CT were compared with those of corresponding histopathologic examinations according to the neck-level system. RESULTS: Histopathology revealed metastases in 70 of 355 nodal levels. Using a best discriminative SUVmax cutoff of 3.65, sensitivity, specificity, and accuracy of FDG-PET/CT on a level-by-level basis were 72.9, 96.8, and 92.1 %; those for CT were 52.9, 98.6, and 89.6 %. Differences in sensitivity and accuracy were significant (p < 0.01). The best cutoff SUVmax on the ipsilateral side was 4.61, with corresponding figures of 81.6, 100, and 94.7 %; that on the contralateral side was 2.41, with figures of 60, 88.4, and 85.4 %. CONCLUSION: FDG-PET/CT with SUVmax is useful for preoperative evaluation of neck-node metastasis from SCC of the pharynx and larynx, especially on the ipsilateral side.
PURPOSE: Our aim was to investigate the diagnostic accuracy of fluorine-18-labeled fluorodeoxyglucose positron emission tomography computed tomography (FDG-PET/CT) relative to CT for detecting neck lymph node metastases in patients with squamous cell carcinoma (SCC) of the hypopharynx, oropharynx, and larynx. METHODS: Thirty-four patients with SCC of the hypopharynx (n = 20), oropharynx (n = 5), and larynx (n = 9) who underwent neck dissection (29 bilateral, 5 unilateral; a total of 355 nodal levels) were assessed. Two observers determined the long-axis diameter and maximum standardized uptake value (SUVmax) of all visible neck nodes. Results of FDG-PET/CT were compared with those of corresponding histopathologic examinations according to the neck-level system. RESULTS: Histopathology revealed metastases in 70 of 355 nodal levels. Using a best discriminative SUVmax cutoff of 3.65, sensitivity, specificity, and accuracy of FDG-PET/CT on a level-by-level basis were 72.9, 96.8, and 92.1 %; those for CT were 52.9, 98.6, and 89.6 %. Differences in sensitivity and accuracy were significant (p < 0.01). The best cutoff SUVmax on the ipsilateral side was 4.61, with corresponding figures of 81.6, 100, and 94.7 %; that on the contralateral side was 2.41, with figures of 60, 88.4, and 85.4 %. CONCLUSION: FDG-PET/CT with SUVmax is useful for preoperative evaluation of neck-node metastasis from SCC of the pharynx and larynx, especially on the ipsilateral side.
Authors: Anthony Nguyen; Adam Luginbuhl; David Cognetti; Katie Van Abel; Voichita Bar-Ad; Charles Intenzo; William Keane; Joseph Curry Journal: Laryngoscope Date: 2013-09-19 Impact factor: 3.325
Authors: Nikos Kastrinidis; Felix P Kuhn; Thomas F Hany; Nader Ahmad; Gerhard F Huber; Stephan K Haerle Journal: Laryngoscope Date: 2013-02-20 Impact factor: 3.325
Authors: Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong Journal: J Nucl Med Date: 2006-05 Impact factor: 10.057
Authors: Christiaan A Krabbe; Pieter U Dijkstra; Jan Pruim; Bernard F M van der Laan; Jacqueline E van der Wal; Joost P Gravendeel; Jan L N Roodenburg Journal: Oral Oncol Date: 2007-02-15 Impact factor: 5.337